Loading…

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

[Display omitted]

Saved in:

Bibliographic Details
Published in:	Blood advances 2021-12, Vol.5 (24), p.5501-5506
Main Authors:	Lázaro-Navarro, Juan, Pimentel-Gutiérrez, Helia Judith, Gauert, Anton, Hagemann, Anja I.H., Eisenschmid, Jassi, Gökbuget, Nicola, Vick, Binje, Jeremias, Irmela, Seyfried, Felix, Meyer, Lüder Hinrich, Debatin, Klaus-Michael, Richer, Kathrin, Bultman, Miriam, Neumann, Martin, Hänzelmann, Sonja, Serve, Hubert, Astrahantseff, Kathy, Rieger, Michael A., Eckert, Cornelia, Baldus, Claudia D., Bastian, Lorenz
Format:	Article
Language:	English
Subjects:	Bridged Bicyclo Compounds, Heterocyclic - pharmacology Casein Kinase II Humans Myeloid Cell Leukemia Sequence 1 Protein Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Research Letter Sulfonamides
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!